Plasma Netrin-1 & cardiovascular risk in children with end stage renal disease

https://doi.org/10.53730/ijhs.v6nS4.6105

Authors

  • Fatina I. Fadel Professor of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt. Head of Pediatric Nephrology & Transplantation Unit, Pediatrics Department, Faculty of medicine, Cairo University Children Hospital, Cairo, Egypt
  • Hanan A Madani Professor of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt. Clinical & Chemical Pathology Department, Faculty of Medicine, Cairo University
  • S M Kamel Lecturer of Radio-diagnosis, Faculty of Medicine, Cairo University, Cairo, Egypt. Pediatric Radiology Unit, Diagnostic and Interventional Radiology department, Faculty of Medicine, Cairo University Children Hospital, Cairo, Egypt
  • Shorouk A. Othman Lecturer of Pediatrics & Pediatric Nephrology, Faculty of Medicine, Cairo University, Cairo, Egypt. Pediatric Nephrology & Transplantation Unit, Pediatrics, Department, Faculty of medicine, Cairo University Children Hospital, Cairo, Egypt
  • Doaa M. Salah Assistant Professor of Paediatrics & Pediatric Nephrology, Faculty of Medicine, Cairo University, Cairo, Egypt. Pediatric Nephrology & Transplantation Unit,Pediatrics Department,Faculty of medicine, Cairo University Children Hospital, Cairo, Egypt

Keywords:

Cardiovascular risk, Hemodialysis, kidney transplantation, Netrin-1, HsCRP, neutrophil lymphocytes ratio, ABPM

Abstract

Background: Cardiovascular disease (CVD) is the most common cause of mortality and morbidity in children with end stage kidney disease (ESKD) which arises from the interaction of several risk factors. The aim of the study is to assess CV risk of ESKD children and outline the impact of KTX on this CV risk. Also valuate the relation between plasma Netrin-1, chronic inflammatory markers and CV risk. Methods: Sixty ESKD (30 on regular hemodialysis (HD), 30 recipients of kidney transplant (KTX)) were assessed using 24 hour AMBP assessment, laboratory (including lipid profile and markers of chronic inflammation namely N/L and HsCRP) and echocardiographic data. Plasma netrin-1 was assessed by ELISA technique for all patients. Results: showed significant higher prevalence of hypertension, higher number of patients with 24hrs BP> 95th percentile by ABPM, more prevalence of nocturnal non-dipping BP, higher percentage of obese and overweight patients, worse biochemical analysis, higher chance of medical calcification by higher Po4 and Ca X Po4, higher triglyceride level and lower HDL level and higher N/L in HD than KTX group. Significant inverse relation was detected between plasma netrin 1 and Hs CRP and between netrin 1 and N/L (p<0.001).

Downloads

Download data is not yet available.

References

Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55: 762–768. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.109.144899

Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T & Unsal A. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clinical nephrology 2016; 85: 199-208.‏ DOI: https://doi.org/10.5414/CN108584

Bandeali S and Farmer J. “High-density lipoprotein and atherosclerosis: The role of antioxidant activity,” Curr. Atheroscler. Rep 2012; 14: 101–107. DOI: https://doi.org/10.1007/s11883-012-0235-2

Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M,

de la Cruz JJ, Ruiz-Hurtado G, Segura J, Rodriguez-Artalejo F,

Williams B. Relationship between clinic and ambulatory

blood-pressure measurements and mortality. N Engl J Med 2018; 378:

–1520

Becker-Cohen, R., Nir, A., Rinat, C., Feinstein, S., Algur, N., Farber, B., & Frishberg, Y. Risk factors for cardiovascular disease in children and young adults after renal transplantation. Clinical Journal of the American Society of Nephrology 2006; 1: 1284-1292.‏ DOI: https://doi.org/10.2215/CJN.01480506

Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive

protein, and risk of future cardiovascular events. Circulation 2003;

: 2993–2999

Bonthuis M, Van Stralen KJ, Jahnukainen T, Laube GF, Podracka L, Seeman T, et al. Dyslipidaemia in children with end-stage renal disease. Pediatr Nephrol 2012; 27:1606

Bonthuis M vSK, Verrina E, Groothoff JW, Alonso Melgar Á, Edefonti A, Fischbach M, Mendes P, Molchanova EA, Paripović D, Peco-Antic A, Printza N, Rees L, Rubik J, Stefanidis CJ, Sinha MD, Zagożdżon I, Jager KJ, Schaefer F. Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. Nephrol Dial Transplant 2013; 28:195- 204 DOI: https://doi.org/10.1093/ndt/gft259

Borchert-Mörlins B, Thurn D, Schmidt B M, Büscher A K, Oh J, Kier T& Melk A. Factors associated with cardiovascular target organ damage in children after renal transplantation. Pediatric Nephrology 2017; 32: 2143-2154.‏ DOI: https://doi.org/10.1007/s00467-017-3771-8

Bruikman C S, Vreeken D, Hoogeveen R M, Bom M J, Danad I, Pinto-Sietsma S J & van Gils J M. Netrin-1 and the grade of atherosclerosis are inversely correlated in humans. Arteriosclerosis, thrombosis, and vascular biology 2020; 40: 462-472.‏ DOI: https://doi.org/10.1161/ATVBAHA.119.313624

Bulum B, Ozcakar ZB, Kavaz A, Tutar E, Ekim M, Yalcinkaya F. Hypertension in children after renal transplantation. Pediatr

Int 2015; 57:1138–1142

Cameron C, Vavilis G, Kowalski J, Tyden G, Berg UB, Krmar RT. Anobservational cohort study of the effect of hypertension

on the loss of renal function in pediatric kidney recipients. Am J

Hypertens 2014; 27:579–585 DOI: https://doi.org/10.1080/08276331.2014.1091187

Chaudhuri A, Sutherland S M, Begin B, Salsbery K, McCabe L, Potter D & Wong C J. Role of twenty-four-hour ambulatory blood pressure monitoring in children on dialysis. Clinical Journal of the American Society of Nephrology 2011'; 6: 870-876.‏ DOI: https://doi.org/10.2215/CJN.07960910

Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2002; 62: 648–653. DOI: https://doi.org/10.1046/j.1523-1755.2002.00472.x

Chavers BM, Solid CA, Daniels FX, Chen SC, Collins AJ, Frankenfield DL & Herzog, CA. Hypertension in pediatric long-term hemodialysis patients in the United States. Clinical Journal of the American Society of Nephrology 2009; 4: 1363-1369.‏ DOI: https://doi.org/10.2215/CJN.01440209

Chavers B M, Solid C A, Sinaiko A, Daniels F X, Chen S C, Collins A J & Herzog C A. Diagnosis of cardiac disease in pediatric end-stage renal disease. Nephrology Dialysis Transplantation 2011; 26: 1640-1645. DOI: https://doi.org/10.1093/ndt/gfq591

Civilibal M, Caliskan S, Oflaz H, Sever L, Candan C, Canpolat N & Arisoy N. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients. Pediatric Nephrology 2007; 22: 1021-1029.‏ DOI: https://doi.org/10.1007/s00467-007-0451-0

Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS.Prevalence of chronic kidney disease and decreased kidneyfunction in the adult US population: third National Health andNutrition Examination Survey. Am J Kidney Dis 2003; 41:1–12 DOI: https://doi.org/10.1053/ajkd.2003.50007

Dai L, Golembiewska E, Lindholm B, Stenvinkel P. End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes. Contrib Nephrol 2017;191: 32-43 DOI: https://doi.org/10.1159/000479254

Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in

children. N Engl J Med 2014; 371: 549-558 DOI: https://doi.org/10.1056/NEJMra1314376

Diez J and Frohlich ED. A translational approach to hypertensive heart disease. Hypertension 2010; 55:1–8 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.109.141887

Elshafie A M, Bahbah M H, Elnemr F M, Ragab S M & Omar Z A S. Carotid intima–media thickness in children with end-stage renal disease on hemodialysis. Menoufia. Medical Journal 2016; 29: 280.‏ DOI: https://doi.org/10.4103/1110-2098.192440

Elshamaa M F, Sabry S, Nabih M, Elghoroury E A, El-Saaid G S & Ismail A A G. Oxidative Stress Markers and C-Reactive Protein in Pediatric Patients on Hemodialysis. Annals of Nutrition and Metabolism 2009; 5:309–316 DOI: https://doi.org/10.1159/000245938

Fadel F, Bazaraa H, Hachem R, Salah D M & Safouh H. Endothelial Dysfunction in Pediatric Renal Transplant Recipients. J Transplant Technol Res 2016; 6: 2161-0991.‏

Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I & Mant D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. The Lancet 2011; 377: 1011-1018.‏ DOI: https://doi.org/10.1016/S0140-6736(10)62226-X

Foster BJ, Leonard MB. Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr 2004; 80:801-814 DOI: https://doi.org/10.1093/ajcn/80.4.801

Foster BJ, Dahhou M, Zhang X, Platt RW, Hanley JA. Change in mortality risk over time in young kidney transplant recipients. Am J Transplant 2011; 11: 2432-2442 DOI: https://doi.org/10.1111/j.1600-6143.2011.03691.x

Galiyeva D. Cardiovascular risk factor prevalence, mortality and cardiovascular disease incidence in patients who initiated renal replacement therapy in childhood; systematic review and analyses of two renal registries 2017.‏

Guo D, Qiao Y, Li Z, Zhu Z, Peng H, Zhang Q & He J. Decreased serum netrin-1 is associated with ischemic stroke: A case–control study. Nutrition, Metabolism and Cardiovascular Diseases 2020; 30: 2328-2334.‏ DOI: https://doi.org/10.1016/j.numecd.2020.07.034

Hadtstein C & Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 2008; 23:363-671 DOI: https://doi.org/10.1007/s00467-007-0643-7

Hamdani G, Nehus EJ, Hooper DK, Mitsnefes MM. Maskedhypertension and allograft function in pediatric and young adults kidney transplant recipients. Pediatr Transplant 2016; 20:1026–1031 DOI: https://doi.org/10.1111/petr.12752

Hamdani G, Nehus EJ, Hanevold CD, Sebestyen Van Sickle J,Woroniecki R, Wenderfer SE, Hooper DK, Blowey D, Wilson A,Warady BA, Mitsnefes MM. Ambulatory blood pressure, leftventricular hypertrophy, and allograft function in children and youngadults after kidney transplantation. Transplantation 2017; 101:150–156 DOI: https://doi.org/10.1097/TP.0000000000001087

Jha V. Current status of end-stage renal disease care in South Asia. Ethn Dis 2009; 19: 27–32.

KDOQI clinical practice guidelines for anemia of chronic kidney disease, 2000. Am J Kidney Dis 2001; 37: 182– 238. DOI: https://doi.org/10.1016/S0272-6386(01)70008-X

KDOQI. Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005; 46: 1-103. DOI: https://doi.org/10.1053/j.ajkd.2005.07.028

KDIGO 2012 Clinical Practice Guideline for theevaluation and management of chronic kidney disease. Kidney Int 2013; 3: 1-150.

Kim H, Ishag M, Piao M, Kwon T, Ryu K. A data mining approach for cardiovascular disease diagnosis using heart rate variability and images of carotid arteries. Symmetry 2016; 8: 47. DOI: https://doi.org/10.3390/sym8060047

Kimura G.Kidney and circadian blood pressure rhythm.Hypertension 2008; 51:827–828 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.108.110213

Kocak H, Ceken K, Yavuz A, Yucel S, Gurkan A, Erdogan O & Tuncer M. Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrology Dialysis Transplantation 2006; 21: 203-207.‏ DOI: https://doi.org/10.1093/ndt/gfi119

Krmar RT & Barany P. Obesity in children with end-stage renal disease. Nature Reviews Nephrology 2013; 9: 707-708.‏ DOI: https://doi.org/10.1038/nrneph.2013.223

Lilien MR and Groothoff JW. Cardiovascular disease in children with CKD or ESKD. Nat Rev Nephrol 2009; 5: 229-235 DOI: https://doi.org/10.1038/nrneph.2009.10

Lin Z, Jin J, Bai W, Li J, Shan X. Netrin-1 prevents the attachment of monocytes to endothelial cells via an anti-inflammatory effect. Mol Immunol 2018; 103: 166–172. DOI: https://doi.org/10.1016/j.molimm.2018.08.021

Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K,

Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O,

Schaefer F. Altered morphologic properties of large arteries

in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16:1494–1500 DOI: https://doi.org/10.1681/ASN.2004110932

Liu T, Zhang Q, Zhang J, Li C, Miao Y R, Lei Q, Guo A Y. EVmiRNA: a database of miRNA profiling in extracellular vesicles. Nucleic Acids Res 2019; 47: 89–93. DOI: https://doi.org/10.1093/nar/gky985

Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine

S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W,

Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ,

Wuhl E, Zanchetti A. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34:1887–1920 DOI: https://doi.org/10.1097/HJH.0000000000001039

Ly NP, Komatsuzaki K, Fraser IP, Tseng A A, Prodhan P, Moore K J & Kinane T B. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102: 14729–14734 DOI: https://doi.org/10.1073/pnas.0506233102

McDonald SP and Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med 2004; 350: 2654-2662. DOI: https://doi.org/10.1056/NEJMoa031643

Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and

classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945–1953. DOI: https://doi.org/10.1038/sj.ki.5000414

Mudi A, Dickens C, Levy C & Ballot D.Cardiovascular risk factors and mortality in children with chronic kidney disease. South African Medical Journal 2017a; 107: 710-714.‏ DOI: https://doi.org/10.7196/SAMJ.2017.v107i8.12271

National Cholesterol Education Program (NCEP). Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89:495–501 DOI: https://doi.org/10.1542/peds.89.3.495

Passacquale G, Phinikaridou A, Warboys C, Cooper M, Lavin B, Alferi A, Andia ME, Botnar RM, Ferro A. Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infltration. Br J Pharmacol 2015; 172: 3548–3564. DOI: https://doi.org/10.1111/bph.13144

Peterson CG and Miyashita Y. The use of ambulatory bloodpressure monitoring as standard of Care in Pediatrics. FrontPediatr 2017; 5:153 DOI: https://doi.org/10.3389/fped.2017.00153

Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391–397. DOI: https://doi.org/10.1161/01.CIR.0000055014.62083.05

Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20. DOI: https://doi.org/10.1056/NEJMoa042378

Roberts J S, Yanay O & Barry D. Age-Based Percentiles of Measured Mean Arterial Pressure in Pediatric Patients in a Hospital Setting. Pediatric Critical Care Medicine 2020; 21: 759-768.‏ DOI: https://doi.org/10.1097/PCC.0000000000002495

Roberts W L, Sedrick R, Moulton L, Spencer A & Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clinical Chemistry 2000; 46: 461-468.‏ DOI: https://doi.org/10.1093/clinchem/46.4.461

Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int 2010; 78:1154-1163 DOI: https://doi.org/10.1038/ki.2010.311

Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD,

Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, de la

Sierra A, Hermida RC, Dolan E, O’Brien E, Roush GC,

Investigators A-H. Prognostic effect of the nocturnal blood

pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) metaanalysis. Hypertension 2016; 67:693–700 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.115.06981

Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM.

C-reactive protein and the risk of developing hypertension. JAMA

; 290: 2945–3951.

Shah S, Swartz S, Campbell J & Srivaths P R. Ambulatory blood pressures and central blood pressures are associated with cardiovascular morbidity in adolescent and young adult patients receiving chronic hemodialysis. Pediatric Nephrology 2019; 34: 1261-1268.‏ DOI: https://doi.org/10.1007/s00467-019-04208-8

Skrzypczyk P, Szyszka M, Ofiara A, Leszczyńska B, Adamczuk D, Daniel M & Pańczyk-Tomaszewska M. Ambulatory blood pressure monitoring and subclinical inflammation in children with chronic kidney disease. Arterial Hypertension 2019; 23: 14-21.‏ DOI: https://doi.org/10.5603/AH.a2019.0003

Solak Y, Yilmaz M I, Sonmez A, Saglam M, Cakir E, Unal H U & Carrero JJ. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clinical and experimental nephrology 2013; 17: 532-540.‏ DOI: https://doi.org/10.1007/s10157-012-0728-x

Staples AO, Greenbaum LA, Smith JM, Gipson DS, Filler G, Warady BA, Wong C S.Association between clinical risk factors and progression of chronic kidney disease inchildren. Clinical Journal of the American Society of Nephrology 2010; 5: 2172-2179. DOI: https://doi.org/10.2215/CJN.07851109

Stompór T, Pasowicz M, Sulłowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E. An association between coronary artery calcification score, lipid profile and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003; 41:203–211. DOI: https://doi.org/10.1053/ajkd.2003.50005

Thompson A M and Pickering T G. The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney international 2006; 70: 1000-1007.‏ DOI: https://doi.org/10.1038/sj.ki.5001695

Vogt BA and Avner ED. Renal failure. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson Textbook of Pediatrics. 18th ed. USA: Saunders; 2007; 2210–2214.

Wang N, Cao Y & Zhu Y. Netrin-1 prevents the development of cardiac hypertrophy and heart failure. Molecular medicine reports 2016; 13: 2175-2181.‏ DOI: https://doi.org/10.3892/mmr.2016.4755

Wilson AC and Mitsnefes MM. Cardiovascular disease in CKD in children: Update on risk factors,risk assessment, and management. Am J Kidney Dis 2009; 54: 345-360 DOI: https://doi.org/10.1053/j.ajkd.2009.04.027

Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20:1995-2007. DOI: https://doi.org/10.1097/00004872-200210000-00019

Yilmaz M I, Sonmez A, Saglam M, Cayci T, Kilic S, Unal H U & Zoccali C. A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation. Clinical Journal of the American Society of Nephrology 2015; 10: 471-479.‏ DOI: https://doi.org/10.2215/CJN.07860814

Zhao P, Xu P, Wan C, Wang Z. Evening versus morningdosing regimen drug therapy for hypertension. Cochrane DatabaseSyst Rev 2011; 4184 DOI: https://doi.org/10.1002/14651858.CD004184.pub2

Published

22-04-2022

How to Cite

Fadel, F. I., Madani, H. A., Kamel, S. M., Othman, S. A., & Salah, D. M. (2022). Plasma Netrin-1 & cardiovascular risk in children with end stage renal disease. International Journal of Health Sciences, 6(S4), 1747–1772. https://doi.org/10.53730/ijhs.v6nS4.6105

Issue

Vol. 6 No. S4 (2022)

Section

Peer Review Articles
Copyright & Licensing

Copyright (c) 2022 International journal of health sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.

Crossref
Scopus
Google Scholar
Europe PMC